Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
The Intergroup | INTG | Apr 26, 2024 | 21.94 | +2.72 |
The J.M Smucker Company | SJM | Apr 26, 2024 | 113.60 | -1.37 |
The Joint | JYNT | Apr 26, 2024 | 12.23 | +1.24 |
The Marygold Companies | MGLD | Apr 26, 2024 | 1.27 | -5.22 |
The ODP | ODP | Apr 26, 2024 | 51.39 | -0.08 |
The OLB Group | OLB | Apr 26, 2024 | 0.36 | +19.92 |
The Oncology Institute | TOI | Apr 26, 2024 | 1.15 | -2.54 |
The ONE Group Hospitality | STKS | Apr 26, 2024 | 5.21 | +1.76 |
The Pennant Group | PNTG | Apr 26, 2024 | 20.78 | +2.31 |
The Real Brokerage | REAX | Apr 26, 2024 | 3.83 | +3.51 |
The Real Estate Select Sector SPDR Fund | XLRE | Apr 26, 2024 | 36.46 | +0.08 |
The RealReal | REAL | Apr 26, 2024 | 3.59 | +5.59 |
The RMR Group A | RMR | Apr 26, 2024 | 23.53 | +1.82 |
The Shyft Group | SHYF | Apr 26, 2024 | 11.26 | +0.27 |
The Trade Desk A | TTD | Apr 26, 2024 | 84.73 | +1.67 |
The9 ADR | NCTY | Apr 26, 2024 | 6.92 | +2.67 |
TherapeuticsMD | TXMD | Apr 26, 2024 | 1.86 | -0.53 |
Theratechnologies | THTX | Apr 26, 2024 | 1.30 | 0.00 |
Theravance Biopharma | TBPH | Apr 26, 2024 | 9.12 | -0.22 |
Thermo Fisher Scientific | TMO | Apr 26, 2024 | 573.60 | +0.33 |
ThermoGenesis | THMO | Apr 26, 2024 | 0.68 | 0.00 |
Thermon Group | THR | Apr 26, 2024 | 31.83 | +0.76 |
Third Coast Bancshares | TCBX | Apr 26, 2024 | 19.90 | +2.00 |
Third Harmonic | THRD | Apr 26, 2024 | 10.83 | +3.54 |
Thomson Reuters | TRI | Apr 26, 2024 | 154.40 | +1.20 |
Thor Industries | THO | Apr 26, 2024 | 100.59 | -0.16 |
Thornburg Income Builder Opportunities Fund | TBLD | Apr 26, 2024 | 15.44 | +0.19 |
Thoughtworks | TWKS | Apr 26, 2024 | 2.39 | +2.58 |
ThredUp A | TDUP | Apr 26, 2024 | 1.61 | -0.62 |
Thryv | THRY | Apr 26, 2024 | 22.85 | -0.13 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.